RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,604,000 | +75.7% | 624,829 | +5.2% | 0.00% | +50.0% |
| Q2 2016 | $3,189,000 | +21.0% | 593,892 | +3.6% | 0.00% | +100.0% |
| Q1 2016 | $2,636,000 | -5.3% | 573,082 | +7.0% | 0.00% | -50.0% |
| Q4 2015 | $2,783,000 | -19.3% | 535,342 | -6.1% | 0.00% | 0.0% |
| Q3 2015 | $3,447,000 | -57.7% | 569,954 | +10.3% | 0.00% | -60.0% |
| Q2 2015 | $8,156,000 | +77.5% | 516,591 | +22.2% | 0.01% | +66.7% |
| Q1 2015 | $4,595,000 | +10.7% | 422,750 | +7.1% | 0.00% | +50.0% |
| Q4 2014 | $4,152,000 | +23.3% | 394,840 | +12.5% | 0.00% | 0.0% |
| Q3 2014 | $3,367,000 | -13.6% | 351,115 | +4.1% | 0.00% | -33.3% |
| Q2 2014 | $3,895,000 | +20.6% | 337,351 | +4.4% | 0.00% | +50.0% |
| Q1 2014 | $3,230,000 | -21.2% | 323,014 | +2.6% | 0.00% | -33.3% |
| Q4 2013 | $4,097,000 | +0.3% | 314,714 | +15.1% | 0.00% | 0.0% |
| Q3 2013 | $4,084,000 | +80.5% | 273,346 | +13.0% | 0.00% | +50.0% |
| Q2 2013 | $2,262,000 | – | 241,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|